Critical Information on the Rampant Spread of a Lethal Fungal Infection in Hospitals

 

Critical Information on the Rampant Spread of a Lethal Fungal Infection in Hospitals

A deadly fungal infection is spreading at “ an  intimidating rate ” inside health  installations and long- term- care hospitals across the United States, the Centers for Disease Control and Prevention said Monday.   Then’s what to know about the  largely  medicine- resistant fungus — a strain of a kind of  incentive known as Candida auris( orC. auris for short) that the CDC says “ presents a serious global health  trouble ”

Candida auris (C. auris) is resistant to several antifungal drugs, and the number of cases has increased every year since it was first reported in 2016. 2020 to 2021 will see the fastest growth, study finds published Monday in Calendar. internal Medicine.

The

cases detected by testing have tripled from 2020 to 2021 to 4041.

The 4,444 cases of infection increased from 476 in 2019 to 1,471 in 2021. 4,444 Seventeen states detected their first cases of Candida auris between 2019 and 2021. 4,444 "The rapid increase and geographic spread of cases are of concern and underscore the need to monitor laboratory capacity expansion, expedite diagnostic testing, and adhere to proven infection prevention and control methods," said lead author Dr Megan Lyman. .

The researchers also looked at the number of infections resistant to echinocandins, the antifungal drug recommended for treatment, which had tripled in the previous two years.

Fungal infections can be life-threatening for those most at risk in hospital settings, including patients who are critically ill, use invasive medical devices or live long-term or frequently in healthcare facilities, the agency said .

What is Candida or Candida?

Candida auris is an antibiotic-resistant fungus that can cause outbreaks in healthcare settings, according to the CDC.

The fungus can infect blood and can even cause death by invading the blood, heart and brain, the agency said. More than a third of patients die from this infection.

The pathogen is also dangerous because it is often resistant to antifungal drugs commonly used to treat the infection, experts say.

It is also difficult to identify without specialized laboratory techniques and is often confused with other infections.

C. auris was first identified in Asia in 2009 and quickly spread globally, according to the agency. Reported cases have increased more than 300% since it began circulating in the United States in 2015.

Candida auris Symptoms of Infection

According to the CDC, Candida auris does not always cause infection and can be carried on the patient's skin and spread more easily to others.

But when it causes an infection, it can be difficult to recognize because it mostly occurs in patients who already have other medical conditions and are showing symptoms, the agency said.

The CDC says fever and chills that do not improve with antibiotics are the most common symptoms of C. auris.

Fight fungal infections

Fungal infections, including Candida auris, are also difficult to treat because antifungal medications can be harmful, experts say.

This makes prevention essential, says Lance B.

Price, professor of environmental and occupational health, and founder and co-director of the Center for Action on Antibiotic Resistance at George Washington University. "The scary thing about Candida auris and any drug-resistant fungal infection is that it's hard to find good, safe antifungal drugs because humans and fungi are made of the same stuff," Price said, who works with the disease. The CDC study has nothing to do with it.

Antifungals are also overused in agricultural settings, which he says leads to more resistant strains.

The increase in C. auris cases may be due to increased surveillance to detect more cases, reduced prevention efforts due to strained healthcare systems during the COVID-19 pandemic, or both, according to the authors of the study.

"Hospitals need to step up screening patients for drug-resistant strains, isolate them, and pave the way for infection control," Price said.

Dig deeper: More health information

Babesia: Tick-borne disease cases more than double in the Northeast

Young deaths: Why rise after years of medical advances

New data reversed : Paxlovid nears full FDA approval